SUN Pharmaceutical Industries Limited — Cephalexin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Cephalexin · $10.6M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #4 Indian exporter of Cephalexin with $10.6M in export value and 294 verified shipments. SUN Pharmaceutical Industries Limited holds a 3.0% market share in Cephalexin exports across 10 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Cephalexin Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Cephalexin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $6.3M | 174 | 77.5% |
| NIGERIA | $657.9K | 47 | 8.1% |
| SOUTH AFRICA | $508.9K | 30 | 6.3% |
| MYANMAR | $181.2K | 12 | 2.2% |
| THAILAND | $169.4K | 19 | 2.1% |
| PERU | $95.8K | 7 | 1.2% |
| UNITED ARAB EMIRATES | $85.2K | 2 | 1.1% |
| OMAN | $52.3K | 4 | 0.6% |
| BRAZIL | $46.9K | 3 | 0.6% |
| ZAMBIA | $22.8K | 7 | 0.3% |
SUN Pharmaceutical Industries Limited exports Cephalexin to 10 countries. The largest destination is AUSTRALIA accounting for 77.5% of SUN Pharmaceutical Industries Limited's Cephalexin shipments, followed by NIGERIA (8.1%) and SOUTH AFRICA (6.3%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cephalexin from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| M/S. SUN PHARMA ANZ PTY LTD | AUSTRALIA | $3.2M | 95 |
| M S SUN PHARMA ANZ PTY LIMITED | AUSTRALIA | $1.5M | 33 |
| M S SUN PHARMA ANZ PTY LTD | AUSTRALIA | $629.8K | 16 |
| M/S. SUN PHARMA ANZ PTY .LTD | AUSTRALIA | $468.7K | 14 |
| MS SUN PHARMA ANZ PTY LIMITED | AUSTRALIA | $272.6K | 11 |
| M/S. SANKIL PHARMACEUTICAL LTD. | NIGERIA | $183.5K | 13 |
| M/S. RANBAXY NIGERIA LIMITED | NIGERIA | $175.4K | 16 |
| M S SANKIL PHARMACEUTICAL LTD | NIGERIA | $173.4K | 11 |
| SUN PHARMA ANZ PTY LIMITED | AUSTRALIA | $168.1K | 5 |
| M S RANBAXY PHARMACEUTICALS PTY LIMITED | SOUTH AFRICA | $107.4K | 5 |
SUN Pharmaceutical Industries Limited supplies Cephalexin to 44 buyers globally. The largest buyer is M/S. SUN PHARMA ANZ PTY LTD (AUSTRALIA), followed by M S SUN PHARMA ANZ PTY LIMITED (AUSTRALIA) and M S SUN PHARMA ANZ PTY LTD (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cephalexin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $108.9M worth of Cephalexin through 5,117 shipments from 223 suppliers to 104 countries, serving 516 buyers globally. SUN Pharmaceutical Industries Limited contributes $10.6M to this total, accounting for 3.0% of India's Cephalexin exports. SUN Pharmaceutical Industries Limited ships Cephalexin to 10 countries through 44 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Cephalexin Exports?
SUN Pharmaceutical Industries Limited's average Cephalexin shipment value is $36.1K per consignment, based on 294 shipments totaling $10.6M. The largest destination is AUSTRALIA (77.5% of SUN Pharmaceutical Industries Limited's Cephalexin exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Cephalexin Exporters?
SUN Pharmaceutical Industries Limited ranks #4 among 223 Indian Cephalexin exporters with a 3.0% market share. The top 3 exporters are ALKEM LABORATORIES LIMITED ($30.9M), LUPIN LIMITED ($30.1M), AUROBINDO PHARMA LTD ($11.8M). SUN Pharmaceutical Industries Limited processed 294 shipments to 10 destination countries.
What Cephalexin Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| APO-CEPHALEXIN CAP 500MG PACK:BOX20s BAT | $610.5K | 14 |
| APO-CEPHALEXIN CAP 250MG PACK:BOX20s BAT | $247.3K | 9 |
| APO-CEPHALEXIN CAP 500MG PACK: Box20s BA | $219.7K | 5 |
| APO-CEPHALEXIN CAP 500MG PACK:BOX20S BATCH:DFE8555A, DFE8556A EACH CAP CONTS.CEPHALEXIN BP EQ TO ANHYDROUS CEPHALEXIN 50NOS | $81.5K | 3 |
| APO-CEPHALEXIN CAP 500MG PACK:BOX20S BATCH:DFF0031A, DFF0065A EACH CAP CONTS.CEPHALEXIN BP EQ TO ANHYDROUS CEPHALEXIN 50NOS | $80.8K | 3 |
| APO-CEPHALEXIN CAP 500MG PACK:BOX20S BATCH:DFE8192A,DFE8193A EACH CAP CONTS.CEPHALEXIN BP EQ TO ANHYDROUS CEPHALEXIN 500NOS | $76.4K | 3 |
| APO-CEPHALEXIN CAP 500MG PACK:BOX20S BATCH:DFF3287A EACH CAP CONTS. CEPHALEXIN BP EQ TO ANHYDROUS CEPHALEXIN 500MG | $57.6K | 2 |
| APO-CEPHALEXIN CAP 250MG PACK:BOX20S BATCH:DFE8269A EACH CAP CONTS.CEPHALEXIN BPEQ TO ANHYDROUS CEPHALEXIN 250MGNOS | $52.8K | 3 |
| APO CEPHALEXIN CAP 500MG PACK Box20s Batch DFE0817A DFE1108A EACH CAP CONTSCEPHALEXIN BP EQ TO ANHYDROUS CEPHALEXI | $50.0K | 1 |
| APO CEPHALEXIN CAP 500MG PACK Box20s Batch DFE1109A DFE1144A EACH CAP CONTSCEPHALEXIN BP EQ TO ANHYDROUS CEPHALEXI | $50.0K | 1 |
SUN Pharmaceutical Industries Limited exports 228 distinct Cephalexin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is APO-CEPHALEXIN CAP 500MG PACK:BOX20s BAT with 14 shipments worth $610.5K.
Regulatory Requirements: Exporting Cephalexin to Key Markets
What SUN Pharmaceutical Industries Limited must comply with to export Cephalexin to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Cephalexin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | LUPIN LIMITED | $30.1M | 601 | 7 | $50.0K |
| 3 | AUROBINDO PHARMA LTD | $11.8M | 242 | 5 | $48.7K |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $10.6M | 294 | 10 | $36.1K |
| 5 | CIPLA LIMITED | $9.2M | 184 | 3 | $50.0K |
| 8 | SANCE LABORATORIES PRIVATE LIMITED | $3.6M | 72 | 8 | $50.0K |
SUN Pharmaceutical Industries Limited ranks #4 among 223 Indian Cephalexin exporters. Average shipment value of $36.1K compared to the market average of $488.4K. The closest competitors by value are LUPIN LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Cephalexin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 873 | 17.1% |
| SAHAR AIR | 744 | 14.5% |
| DELHI AIR CARGO ACC (INDEL4) | 538 | 10.5% |
| NHAVA SHEVA SEA (INNSA1) | 398 | 7.8% |
| DELHI AIR | 340 | 6.6% |
| JNPT/ NHAVA SHEVA SEA | 275 | 5.4% |
| JNPT | 220 | 4.3% |
| Bombay Air | 163 | 3.2% |
What Other Antibiotics Products Does SUN Pharmaceutical Industries Limited Export?
SUN Pharmaceutical Industries Limited also exports these antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Cephalexin Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Cephalexin, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cephalexin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cephalexin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 305 individual customs records matching SUN Pharmaceutical Industries Limited exporting Cephalexin, covering 228 formulations to 10 countries via 44 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 516+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cephalexin Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Cephalexin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Cephalexin Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cephalexin. For current shipment-level data, contact TransData Nexus.